Correlation Between Mineralys Therapeutics, and Ultra Clean

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Ultra Clean at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Ultra Clean into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Ultra Clean Holdings, you can compare the effects of market volatilities on Mineralys Therapeutics, and Ultra Clean and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Ultra Clean. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Ultra Clean.

Diversification Opportunities for Mineralys Therapeutics, and Ultra Clean

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Mineralys and Ultra is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Ultra Clean Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultra Clean Holdings and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Ultra Clean. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultra Clean Holdings has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Ultra Clean go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Ultra Clean

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Ultra Clean. In addition to that, Mineralys Therapeutics, is 2.08 times more volatile than Ultra Clean Holdings. It trades about -0.01 of its total potential returns per unit of risk. Ultra Clean Holdings is currently generating about 0.26 per unit of volatility. If you would invest  3,345  in Ultra Clean Holdings on September 1, 2024 and sell it today you would earn a total of  498.00  from holding Ultra Clean Holdings or generate 14.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Ultra Clean Holdings

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Ultra Clean Holdings 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ultra Clean Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Ultra Clean unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics, and Ultra Clean Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Ultra Clean

The main advantage of trading using opposite Mineralys Therapeutics, and Ultra Clean positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Ultra Clean can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultra Clean will offset losses from the drop in Ultra Clean's long position.
The idea behind Mineralys Therapeutics, Common and Ultra Clean Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance